LEGEND BIOTECH HIGHLIGHTS NEW CARVYKTI® DATA IN MULTIPLE MYELOMA AND FIRST-IN-HUMAN RESULTS FROM NOVEL CAR-T PLATFORM IN NON-HODGKIN LYMPHOMA AT ASH 2025

Reuters · 1d ago

Please log in to view news